Centre Hospitalier Departemental Vendee   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Lucon France (2003)

Organization Overview

First Clinical Trial
2009
NCT00847938
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Centre Hospitalier Departemental Vendee | Centre Hospitalier Départemental Vendée | CHD Vendée

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (Phase 3)

Kidney Calculi (Phase 3)

Kidney Diseases (Phase 3)

Kidney Failure, Chronic (Phase 4)

Osteoarthritis (Phase 4)

Polycystic Ovary Syndrome (Phase 4)

Renal Insufficiency (Phase 4)

Syndrome (Phase 4)

Vasculitis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 14
  • # of Trial APIs: 16